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Macrophage cultures pulsed with viable Mycobacterium leprae were assessed
for erythrocyte rosetting in three groups of individuals, i.e., normal subjects, and
tuberculoid and lepromatous patients. Of these, only the lepromatous group
showed a reduction in rosetting ability after infection with M. leprae. The
specificity of such a reduction pattern was confirmed by using various mycobacte-
ria to infect the macrophages. A threshold effect was noted in all three groups.
Although a reduction was obtained in the amount of rosetting of macrophages
from lepromatous patients with 104 acid-fast bacilli per culture, tuberculoid and
normal macrophages resisted such an effect with as large a dose as 20 x 106 to 30
x 106 and 30 x 106 bacilli per culture, respectively. The M. leprae-caused
alterations in macrophages from lepromatous patients were reversible by treat-
ment with trypsin and colchicine. Cytochalasin B and Tween 80 were unable to
alter the pattern. Treatment of cells with neuraminidase was inconclusive since it
enhanced rosetting values of both control and infected cultures. These manipula-
tions were significant in elucidating the target point of the host (macrophage) and
parasite (M. leprae) interaction and in delineation of the external and internal
effects upon the macrophages. Both M. leprae and macrophages were participants
in Fc reduction, as treatment of the former with rifampicin and of the latter with
cyclocheximide significantly augmented the rosetting ability. In conclusion, it
appears that M. leprae, upon entering a lepromatous macrophage, initiates the
production of a protein which acts via the microtubules to alter membrane
topography. It is possible that the altered membrane prevents effective macro-
phage-lymphocyte interaction. This could be one of the mechanisms by which
cell-mediated immunity is suppressed in lepromatous leprosy.
In lepromatous leprosy, the patient is incapa-
ble of developing a cell-mediated immune re-
sponse against Mycobacterium leprae, and ba-
cilli are found to reside intracellularly in large
numbers in macrophages. This parasitism re-
sults from an interaction between the macro-
phages and M. leprae, and it has been suggested
(7) that the outcome of-this interaction may
culminate in the symptoms and pathology asso-
ciated with this spectrum of the disease.
We have studied several parameters to deter-
mine the altered metabolism of the infected
macrophage, such as protein synthesis (3) and
the production of a suppressor factor (12). In
this paper, an attempt has been made to ascer-
tain how the parasitized macrophage communi-
cates with its surroundings. Since receptors are
the prime mode of cellular communication, in
the present study attention has been focused on
the Fc receptors as markers for the integrity of
the macrophage membrane.
The Fc receptors are of considerable signifi-
cance in the phagocytosis of opsonized parti-
cles, antibody-dependent cellular cytotoxicity
(14), and have been implicated in the etiology of
the inflammatory signals in granuloma formation
(2). The importance of this receptor in the partic-
ipation of the macrophage in the immune re-
sponse makes it an ideal marker for this study.
MATERIALS AND METHODS
Choice of patients. Leprosy patients were classified
according to the Ridley and Jopling classification (10).
The lepromatous patients were further subdivided into
long-term-treated lepromatous patients who were bac-
teriologically negative (BI-ve), i.e., did not demon-
strate acid-fast bacilli (AFB) in skin smears, and
bacteriologically positive patients who demonstrated
AFB in their skin smears.
Macrophages. Mononuclear cells were isolated from
heparinized peripheral blood by sedimentation in 6%
dextran and freed from most of the lymphocytes by
adherence to glass. The macrophages thus obtained
were maintained for 7 days in minimal essential medi-
um containing 40%o human AB serum. The culture
medium was changed every 48 h. This resulted in an
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FIG. 1. Infection of macrophages from normal sub-
jects and from leprosy patients in vitro with viable M.
leprae. The hatched area represents the range of
percentage of EA rosetting of uninfected cultures,
whereas each dot (0) represents the rosetting levels of
macrophages (from individual patients) infected with
M. leprae. BI + ve, Bacteriologically positive pa-
tients.
enriched macrophage culture checked morphological-
ly by nonspecific esterase staining.
Source ofM. leprac. Biopsies of nodules from lepro-
matous patients were homogenized and then treated
with trypsin. The M. leprae cells thus obtained after
differential centrifugation were washed with saline,
stored at 4°C, and used within a week (1).
Infection of macrophage monolayers. A total of 5 x
106 bacilli were added to each Leighton tube culture.
The cultures were incubated for 24 h before the
uningested M. leprae were washed off.
Fc-mediated EA rosetting. Infected cultures were
maintained for 72 h before erythrocyte rosetting (EA
rosetting) was carried out. Sheep erythrocytes (SRBC)
in a 2% suspension in minimal essential medium were
sensitized with an equal volume of goat anti-SRBC
antibody. A suspension of 1% sensitized SRBC was
overlaid onto the macrophage monolayer and allowed
to rosette for 30 min at 37°C under 5% CO2. Nonroset-
ted SRBC were removed by washing, and the mono-
layers were fixed in 2.5% glutaraldehyde and stained
with Ziehl-Neelsen acid-fast stain to identify M. lep-
rae. The percentage of cells with two or more SRBCs
attached was determined. A total of 200 cells were
counted.
Treatment with trypsin. The macrophage monolayer
was treated with trypsin (no. 0152; Difco Labora-
tories) for 10 min at 37?C under 5% CO2. The concen-
trations of trypsin used were 0.125 and 0.05%.
Treatment with neuraminidase. The macrophages
were treated with 5 U of neuraminidase (no. N2876;
Sigma Chemical Co.) per ml for 12 min at 37°C under
5% CO2.
Treatment with coichidne or cytochalasin B. Macro-
phages were exposed to 10-5 M colchicine (no. C9754;
Sigma) or 10 1Lg of cytochalasin B (no. C6762; Sigma)
per ml for 1 h at 37°C under 5% CO2. EA rosetting of
the macrophages after the above treatments was car-
ried out to determine the effect of each substance.
Treatment with Tween 80. Tween 80 (0.1%; no.
P1754; Sigma) was added to the macrophages for 1 h at
37°C under 5% CO2.
Treatment with cycloheximde. Macrophages were
incubated with 2 ,ug of cycloheximide (no. C6255;
Sigma) per ml. In one set of experiments, M. leprae
and cycloheximide were added simultaneously and
incubated overnight. These macrophage cultures were
maintained in medium containing cycloheximide after
excess M. leprae was washed off. EA rosetting was
carried out the next day.
In a second set of experiments, 24 h after M. leprae
infection of the macrophage cultures, cycloheximide
was added for 48 h before EA rosetting was done.
Treatment with rifampicin. Rifampicin (10 p.g/ml;
no. R3501; Sigma) was added to the macrophage
culture 24 h before M. leprae infection. After the
excess M. leprae was washed off, the cultures were
maintained for an additional 48 h in medium containing
rifampicin.
RESULTS
Infection of macrophages from normal subjects
and from leprosy patients in vitro with viable M.
keprae. There were no significant differences in
the numbers of macrophages from normal sub-
jects and tuberculoid and lepromatous patients
that phagocytized M. leprae. The values were
52, 58, and 72%, respectively.
Macrophages from normal subjects and from
long-term-treated tuberculoid patients did not
show any significant difference in EA rosetting
of macrophages after M. leprae infection when
compared with control cultures. However, a
significant decrease (P < 0.005) was seen in
treated lepromatous (BI-ve) patient macro-
phages infected with M. Ieprae when compared
with a control culture of the same patient (Fig.
so
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FIG. 2. Infection of macrophages from leproma-
tous patients with other mycobacteria. The results are
expressed as the mean of three experiments. MO,
Cultivable mycobacterium from a nodule of a leproma-
tous patient. Supplied by L. Kato, Institute of Micro-
biology, University of Montreal, Quebec, Canada. M.
delhi, Isolated from soil. Supplied by G. P. Talwar, All
India Institute of Medical Sciences, New Delhi, India.
ICRC, Cultivable AFB isolated from lepromatous nod-
ules. Supplied by C, V. Bapat, Cancer Research
Institute, and E. Borges Marg, Parel, Bombay 400012,
India. M. intra, M. intracellulare; M. hab, M. habana;
M. scrof, M. scrofulaceum; M. smeg, M. smegmatis;
H37ra, M. tuberculosis H37ra (avirulent strain); lepro-
min, heat-killed M. Ieprae; M+), macrophage.
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1). In macrophage cultures from bacteriological-
ly positive lepromatous patients, the amount of
EA rosetting was reduced in the control cul-
tures, and so no additional decrease was evident
upon in vitro M. leprae challenge.
Infection of macrophages from lepromatous
patients with other mycobacteria. Treated lepro-
matous patients (BI-ve) were used in this study
to see if their macrophages also behaved abnor-
mally with other mycobacteria. Our data demon-
strate that reduced EA rosetting was not ob-
served in response to any of the other
mycobacteria tested. Interestingly, autoclaved
M. leprae also failed to reduce the percentage of
rosetting cells (Fig. 2).
Dose response. Various doses of M. leprae
were added to macrophages from normal sub-
jects and from leprosy patients (Fig. 3). In
lepromatous cultures, a reduction in EA roset-
ting was seen with 104 M. Ieprae cells per culture
tube, and upon an additional increase to 2 x 1
M. leprae cells per culture tube, the rosetting
was completely abrogated. However, in cultures
from normal individuals, there were no signifi-
cant decreases observed in rosetting ability even
upon the addition of 3 x 107 M. leprae cells per
culture. Macrophages of tuberculoid patients
had an intermediary threshold dose and demon-
strated a 45% decrease in rosetting at a dose of
20 x 106 M. Ieprae cells per culture.
The drop in rosetting levels of macrophages
from lepromatous patients with such small num-
bers of bacilli can be visualized better from the
data in Fig. 4. Macrophages from infected cul-
tures have been divided into two populations,
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FIG. 3. Various doses of M. leprae added to mac-
rophages from normal individuals and from leprosy
patients. The results are expressed as the mean of two
experiments. Symbols: 0, Macrophages from lepro-
matous patients; *, macrophages from tuberculoid
patients; A, macrophages from normal individuals.
The rosetting values of macrophages cultures not
infected in vitro with M. leprae have been considered
as baseline (0o difference). Percent difference is cal-
culated between the EA rosetting levels of the control
uninfected culture and the M. leprae-infected cultures.
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FIG. 4. EA rosetting of macrophages from lepro-
matous (BI-ve) patients in the presence of viable M.
leprae. C, Control, uninfected macrophage culture; I,
M. leprae-infected macrophage culture; M+, macro-
phages with no intracellular M. leprae; M4ML, macro-
phages with intracellular M. leprae. Control versus
M+ P < 0.005; MO versus M4ML, not significant.
macrophages containing intracellular M. leprae
and macrophages not containing intracellular M.
leprae. The possibility of a soluble factor that
affects the macrophages with no intracellular M.
leprae is discussed below.
Effect of neuraminidase and Tween 80. Neur-
aminidase and Tween 80 had no significant ef-
fects on the M. leprae-induced reduction in EA
rosetting (Fig. 5a and b), although with neur-
aminidase treatment the percentage of rosetting
cells increased in both control and M. leprae-
infected cultures; however, the M. leprae-in-
duced decrease was still evident (Fig. 5a).
Effect of trypsin. Both concentrations of tryp-
sin used were able to nullify the effect of M.
leprae on macrophages and return the percent-
age of EA rosetting to normal levels (Fig. 6a and
b). This reversal was, however, temporary,
since further incubation of the cultures after
trypsin had been washed off reduced the roset-
ting level again (Fig. 6c). The moiety affected by
the interaction between the lepromatous macro-
phage and the pathogenic M. leprae and respon-
sible for the alteration in Fc levels was extreme-
ly trypsin sensitive, since 0.05% trypsin (Fig. 6a)
could also nullify its effect while not having any
direct effect on the Fc receptors themselves.
Effects of cytochalasin B and coichicine. The
M. leprae-induced alteration in EA rosetting
was abolished when cultures were treated with
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FIG. 5. Effect of treatment with neuraminidase or
Tween 80 on macrophages from lepromatous (BI-ve)
patients. Each symbol represents the results obtained
with macrophage cultures from a lepromatous patient;
0, untreated macrophage culture; 0, macrophage
culture treated with neuraminidase or Tween 80; C,
uninfected macrophage culture; +M.lep, M. leprae-
infected macrophage culture.
colchicine (P < 0.005) (Fig. 7a), but not with
cytochalisin B (Fig. 7b). Thus, microtubule, but
not microfilament, involvement is indicated in
the reduction of the rosetting ability of leproma-
tous macrophages containing M. leprae.
Effects of cycloheximide and rifampicin. It is
evident from the data presented in Fig. 8 that the
levels of EA rosetting were restored if cyclohex-
imide was added together with M. leprae in both
macrophage populations, i.e., macrophages con-
taining intracellular M. leprae and macrophages
without intracellular bacilli. However, if M.
leprae was added 48 h before the addition of
cycloheximide, only the macrophages with no
intracellular bacilli showed improved levels of
rosetting (Fig. 8). In uninfected cultures treated
with cycloheximide, there was no deviation
from control values.
If M. Ieprae metabolism was blocked with
rifampicin, a known antileprosy drug, the reduc-
tion in the amount of EA rosetting seen in M.
Ieprae-infected macrophage cultures without ri-
fampicin was not exhibited (Fig. 9).
This suggests that metabolically active macro-
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phages and M. leprae was required for the
reduction in the EA rosetting ability of the
macrophages.
DISCUSSION
Knowledge of the organization and dynamics
of the membrane is a prerequisite for any useful
attempt to build models on how various inflam-
matory signals can be transduced through the
membrane. Such dynamic processes could be
studied by the expression of receptors on the
membrane.
The data of Amsden and Boros (2) revealed
marked differences in cell kinetics and the dis-
play and specificity of Fc receptors of macro-
phages obtained from various granulomas.
These differences seemed related to the etiology
of the granuloma and to the intensity and dura-
tion of the inflammatory signals that prevailed in
the lesions. Similar studies have been carried
out for leprosy by Ridley et al. (11). The lowered
levels of Fc receptors have also been implicated
in the pathogenesis of Sjogren's disease (4).
This study demonstrates that macrophages
from lepromatous patients respond abnormally
by a reduction in EA rosetting values when
challenged with viable M. leprae. Long-term-
treated lepromatous patients who are bacterio-
logically negative have normal numbers of roset-
ted macrophages which are once again reduced
upon exposure to M. leprae in vitro. These
results stress the importance of classifying the
lepromatous patients according to their bacterio-
logical status when conducting immunological
studies and also stress the importance of study-
ing so-called cured patients.
The characteristic pattern of reduced levels of
EA rosetting in lepromatous macrophages
emerged only with viable M. leprae challenge
and not with lepromin (heat-killed M. leprae)
challenge. It could therefore be reasoned that
the effect of M. Ieprae on the membrane was
perhaps via an M. leprae-derived metabolic
product acting on the macrophage.
Additional confirmation was obtained by us-
ing rifampicin, a known bactericidal drug for M.
leprae. In the presence of rifampicin, M. leprae
did not reduce the amount of EA rosetting of
lepromatous macrophages. However, host cell
metabolism was of equal importance since si-
multaneous addition ofM. leprae and cyclohexi-
mide, an inhibitor of protein synthesis in eucary-
otes, to lepromatous macrophage cultures did
not reduce the amount of EA rosetting.
The fact that in vitro M. leprae challenge
brought about a reduction in the EA rosetting
values from a near-normal level in lepromatous
(BI-ve) individuals indicated that such a charac-
ter formed an intrinsic trait of susceptible mac-
rophages. To test this, 24 familial contacts of
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FIG. 6. Effect of trypsin on EA rosetting of macrophages from lepromatous (BI-ve) patients. (a) Treatment of
control and M. leprae-infected cultures with trypsin (concentration, 0.05%). Closed symbols, EA rosetting of
cultures treated with trypsin; open symbols, EA rosetting of cultures not treated with trypsin; C, uninfected
macrophage culture; +M.lep, M. Ieprae-infected macrophage culture; 1, not significant; 2, P < 0.005; 3, P <
0.005; 4, P < 0.005. (b) Treatment of control and M. leprae-infected cultures with trypsin (concentration,
0.125%). Closed symbols: EA rosetting of cultures treated with trypsin; open symbols, EA rosetting of cultures
not treated with trypsin. (c) Effect of prolonged incubation of infected cultures after removal of trypsin from
culture medium. Symbols and abbreviations: 0, trypsin-treated infected cultures; 0, infected cultures not
treated with trypsin; U, EA rosetting in untreated infected cultures; tryp., EA rosetting in trypsin-treated
infected cultures; inc., EA rosetting on prolonged incubation (6 days) after removal of trypsin.
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FIG. 7. Effect of treatment with colchicine or cyto-
chalasin B on macrophages from lepromatous (BI-ve)
patients. *, *, A, V, EA rosetting in uninfected
cultures treated with colchicine or cytochalisin B; O,
O, A, V, EA rosetting in infected cultures not treated
lepromatous leprosy patients were tested for
their ability to express Fc receptors in control
cultures and in cultures infected with M. leprae.
Macrophages from six contacts showed an abili-
ty to react to M. leprae similar to macrophages
from lepromatous patients (unpublished data).
The association between genetic markers and
susceptibility to lepromatous leprosy has also
been demonstrated by other workers (6, 9).
That an inhibitory factor (protein) does result
from an lepromatous macrophage-M. leprae in-
teraction is evident from Fig. 4 and 8. The
results with cycloheximide show that the inhibi-
tory factor is produced in the early stages of the
interaction, since a lapse of 48 h between antigen
addition and cycloheximide addition does not
result in an increase in rosetting activity of cells
harboring AFB. However, cells not harboring
intracellular AFB do not show any depression.
The results, therefore, implicate two steps that
cause suppression. The first is a stable, early-
interaction product produced intracellularly by
the macrophage in the presence of M. Ieprae
with colchicine or cytochalisin B; 0, untreated macro-
phage culture; 0, macrophage culture treated with
colchicine or cytochalasin B; C, uninfected macro-
phage culture; +M.lep, M. leprae-infected macro-
phage culture.
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FIG. 8. Effect of cycloheximide on EA rosetting.
Abbreviations and symbols: C, uninfected macro-
phage cultures; I, M. leprae-infected macrophage cul-
tures; M4, macrophages without intracellular M. le-
prae; M+ML, macrophages with intracellular M.
leprae; 0, A, 0, untreated cultures. M, A, 0, cultures
treated with cycloheximide. Each symbol in all three
panels denotes a single patient. 1 versus 4, Not signifi-
cant; 5 versus 6, not significant; 8 versus 9, P < 0.005;
4 versus 5, not significant; 7 versus 8, P < 0.005.
(12). The second mediates amplification, since
macrophages containing intracellular M. leprae
secrete a soluble product which suppresses the
rosetting ability of macrophages without intra-
cellular bacilli. Additional evidence that such a
factor exists is being published elsewhere.
Although the sites of action of colchicine and
trypsin are different, temporary reversibility of
the depression of EA rosetting remained the
final outcome of treatment with these com-
pounds. This lends support to the probability
that the receptors are present and that their
synthesis is not blocked by intracellular M.
leprae but that the receptors are not available.
Colchicine may unmask these receptors by de-
polymerizing the microtubules (8), which in turn
affects the mobility of the receptors, whereas
trypsin may digest some external proteins,
which allows for the reexpression of the recep-
tors.
Unless there is in vivo conditioning by a
blocking antibody, it is difficult to imagine a
blocking antibody playing an effector role since
the long culture time would certainly result in
antibody dissociation from the cell membrane.
Also, the depression in macrophage EA roset-
ting is manifested only by the addition of M.
leprae in vitro, exclusive of the presence of any
specific antibody.
Although at present it is difficult to visualize
the exact mechanism involved, we have prelimi-
nary indications that Fc receptor expression
alone is not altered and that there are alterations
in other membrane-bound moieties (concanava-
lin A receptors, HLA-D/DR antigens [common
determinants]), indicating a more widespread
membrane change.
A dose-induced immune response threshold
operates in the lepromatous patient. Perhaps a
genetic- or otherwise-controlled disposition may
not allow their macrophages to function normal-
ly if confronted with a dose of 104 M. Ieprae per
culture. The same dose, however, would be
highly immunogenic for a normal or tuberculoid
individual, each group possessing its own
threshold dose. This defect in lepromatous pa-
tients may be genetic, operating with environ-
mental factors such as the route of infection (13).
So far, M. leprae has only been characterized
by means of ambiguous markers, such as mor-
phology and staining properties, and by cumber-
some experimental procedures such as footpad
growth curves. Monitoring of Fc receptors on
lepromatous macrophage cell membranes can be
used as an identification marker for pathogenic
M. leprae or for identifying cultivated M. leprae,
because of the unusual degree of specificity of
this technique.
control rifampicin
leprae-infected cultures. Abbreviations and symbols:
C, uninfected macrophage cultures; I, M. leprae-
infected macrophage cultures; M+0, macrophages with-
out intracellular M. leprae; MWML, macrophages with
intracellular M. leprae; O, A, O, untreated cultures;
*, A, *, cultures treated with rifampicin. Each sym-
bol in both panels denotes a single patient. 1 versus 4,
Not significant; 3 versus 6, P < 0.005.
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In conclusion, it appears that M. leprae, upon
entering lepromatous macrophages, initiates the
production of a protein(s) which acts via the
microtubules to alter membrane topography.
This alteration is extremely trypsin sensitive.
The infected macrophage also releases a factor
into the environment which is responsible for
the amplification of the defect in other macro-
phages. It is possible that the altered membrane
prevents effective macrophage-lymphocyte in-
teraction. This could be one of the mechanisms
by which cell-mediated immunity is suppressed
in lepromatous leprosy. Macrophages have also
been implicated in the reduced cell-mediated
immunity found in lepromatous leprosy.
The importance of monitoring macrophage
receptors in other infectious disease remains
hypothetical until additional data are gathered.
However, it would be attractive to imagine
sequestration of receptors as a distinctive char-
acter of a "suppressor macrophage" or as a
measure of specific susceptibility, or both. More
generally, it may serve to unify suppressor inter-
actions in a group of related infectious diseases.
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